{"disease":{"id":"progeria","name":"progeria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04512963","title":"Phase I Study of Progerinin in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"PRG Science & Technology Co., Ltd.","has_results":false},{"nct_id":"NCT00094393","title":"Clinical Studies of Progeria","phase":"","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT03871972","title":"Umbilical Cord Blood Transfusion in Progeria Syndrome","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Bundang CHA Hospital","has_results":false},{"nct_id":"NCT03895528","title":"Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Eiger BioPharmaceuticals","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}